Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
After finishing at $34.08 in the prior trading day, Ideaya Biosciences Inc (NASDAQ: IDYA) closed at $33.64, down -1.29%. In other words, the price has decreased by -$1.29 from its previous closing price. On the day, 0.99 million shares were traded. IDYA stock price reached its highest trading level at $34.98 during the session, while it also had its lowest trading level at $33.12.
Ratios:
Our goal is to gain a better understanding of IDYA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.44 and its Current Ratio is at 12.44. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
On September 18, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $50.
On September 04, 2025, Citizens JMP started tracking the stock assigning a Mkt Outperform rating and target price of $41.Citizens JMP initiated its Mkt Outperform rating on September 04, 2025, with a $41 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IDYA now has a Market Capitalization of 2949097984 and an Enterprise Value of 2189448960. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.73 while its Price-to-Book (P/B) ratio in mrq is 2.70. Its current Enterprise Value per Revenue stands at 10.191 whereas that against EBITDA is -10.611.
Stock Price History:
The Beta on a monthly basis for IDYA is 0.05, which has changed by 0.32195497 over the last 52 weeks, in comparison to a change of 0.13042927 over the same period for the S&P500. Over the past 52 weeks, IDYA has reached a high of $37.08, while it has fallen to a 52-week low of $13.45. The 50-Day Moving Average of the stock is 7.86%, while the 200-Day Moving Average is calculated to be 41.85%.
Shares Statistics:
The stock has traded on average 1.14M shares per day over the past 3-months and 1015770 shares per day over the last 10 days, according to various share statistics. A total of 87.67M shares are outstanding, with a floating share count of 83.79M. Insiders hold about 4.42% of the company’s shares, while institutions hold 104.59% stake in the company. Shares short for IDYA as of 1764288000 were 7717025 with a Short Ratio of 6.75, compared to 1761868800 on 7859556. Therefore, it implies a Short% of Shares Outstanding of 7717025 and a Short% of Float of 10.39.
Earnings Estimates
. The current assessment of Ideaya Biosciences Inc (IDYA) involves the perspectives of 17.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.93, with high estimates of -$0.74 and low estimates of -$1.07.
Analysts are recommending an EPS of between -$0.69 and -$1.48 for the fiscal current year, implying an average EPS of -$1.21. EPS for the following year is -$3.51, with 17.0 analysts recommending between -$2.31 and -$4.63.
Revenue Estimates
17 analysts predict $5.95M in revenue for. The current quarter. It ranges from a high estimate of $22.2M to a low estimate of -$1.6M. As of. The current estimate, Ideaya Biosciences Inc’s year-ago sales were $7M
A total of 18 analysts have provided revenue estimates for IDYA’s current fiscal year. The highest revenue estimate was $275M, while the lowest revenue estimate was $207.8M, resulting in an average revenue estimate of $217.28M. In the same quarter a year ago, actual revenue was $7M
